Erratum to Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse [Bone 87 (2016) 161-168]
Bone
.
2016 Aug:89:86.
doi: 10.1016/j.bone.2016.05.007.
Epub 2016 Jun 1.
Authors
Dongye Zhang
1
,
Minyi Hu
1
,
Timothy Chu
1
,
Liangjun Lin
1
,
Jingyu Wang
1
,
Xiaodong Li
2
,
Hua Zhu Ke
3
,
Yi-Xian Qin
1
Affiliations
1
Dept. of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794-5281, United States.
2
Dept. of Metabolic Disorders, Amgen, Inc., Thousand Oaks, CA, United States.
3
UCB Pharma, Slough, UK.
PMID:
27262889
PMCID:
PMC7144583
DOI:
10.1016/j.bone.2016.05.007
No abstract available
Publication types
Published Erratum
Grants and funding
R01 AR049286/AR/NIAMS NIH HHS/United States
R01 AR052379/AR/NIAMS NIH HHS/United States
R01 AR061821/AR/NIAMS NIH HHS/United States